{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
NCT04669899: Phase 1/Phase 2 Interventional Completed Cancer
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03481946: Phase 1 Interventional Completed Hemophilia A; Hemophilia B
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:lorigerlimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03261739: Phase 1 Interventional Completed NAFLD
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:manfidokimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04139902: Phase 2 Interventional Recruiting Melanoma Stage III
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:alomfilimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04705350: Phase 1 Interventional Completed Healthy Study Participants
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:trastuzumab botidotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03507452: Phase 1 Interventional Completed Advanced Recurrent Malignant Pleural Epithelioid Mesothelioma
(2018)
Source URL:
Class:
PROTEIN